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Background: Delayed neuropsychological sequelae (DNS) are the most severe and clinically intractable
complications following acute carbon monoxide (CO) poisoning. Symptoms of DNS often resemble those of
Parkinson’s disease (PD), suggesting shared neurological deficits. Furthermore, Parkinson protein 2 (PARK2)
mutations are associated with PD and other neurodegenerative diseases. The association signal was detected
between PARK2 and DNS after acute CO poisoning in our DNA pooling base genome-wide association study.
Methods: Two PARK2 single nucleotide polymorphisms (SNPs), rs1784594 (C/T allele) and rs1893895 (G/A allele),
selected from DNA pooling base genome-wide association study, were genotyped by in 514 CO poisoning patients
using polymerase chain reaction restriction fragment length polymorphisms (PCR-RFLPs). The patient group
consisted of 231 patients with DNS and 283 patients with no signs of lasting neurological damage (control
population).
Results: The frequency of the rs1784594 T allele was significantly lower in the DNS population (OR = 1.42, 95%CI:
1.08 − 1.87), as was the TT vs. CC genotype (OR = 1.95, 95%CI: 1.15 − 3.23) and the TT vs. CT + CC frequency (OR =
1.68, 95%CI: 1.32 − 2.49) compared to controls. Association analysis revealed a significant association between DNS
and rs1784594 (P < 0.01) but not rs1893895 (P > 0.05). In female cases, the T allele frequency of rs1784594 was
significantly lower in DNS patients compared to female controls (OR = 1.48, 95%CI: 1.01 − 2.17).
Conclusion: These data suggest that the allelic variant of rs1784594 is a risk factor for DNS following acute CO
poisoning, especially in females. The PARK2 protein may modulate the susceptibility to DNS, underscoring the
importance of examining the relationship between other PARK2 polymorphisms and clinical outcome following CO
poisoning.
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Inhalation of carbon monoxide (CO) in quantities sufficient
to cause systemic tissues hypoxia is termed acute CO poi-
soning. Carbon monoxide inhalation is a relatively common
cause of home fatalities and a significant occupational
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reproduction in any medium, provided the orrecover from the acute stage of CO intoxication only to ex-
hibit a recurrence of neuropsychiatric symptoms after a la-
tent period (usually 3 to 60 days) of normal or near normal
neurological function termed the lucid interval. These
symptoms are termed delayed neuropsychological sequelae
(DNS) after CO poisoning [2,3] and are thought to arise
from delayed post-hypoxic leukoencephalopathy (DPHL).
The earliest epidemiological study of DPHL, taken from
New York hospital records dating from 1925 to 1935, docu-
mented 13 cases of late-onset neurological and psychiatric
symptoms following acute CO poisoning that meet current
DNS diagnostic criteria [4]. The incidence of DPHL istd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gressively with age, while it is rare in children under 10 years
and shows no significant gender differences [5,6]. About
25% of DNS cases result in permanent neuropsychological
deficits. Identification of the most vulnerable patient groups
combined with early diagnosis may improve the quality
of care and reduce permanent disability following CO
toxicity [7].
The signs and symptoms of DNS, including gait and
motor disturbances, cognitive impairments, anxiety, de-
pression, and insomnia, resemble those of Parkinson’s
disease (PD) and Parkinson-like syndromes [7,8], suggesting
common sites of neural damage and similar pathogenic
mechanisms. Mutations in the Parkinson protein 2 gene
(PARK2) are associated with autosomal recessive juvenile
Parkinson’s disease [9]. To study the risk of PD, several
single-nucleotide polymorphisms (SNPs) of PARK2 have
been investigated [10-12]. Given the clinical resemblance of
PD and DNS, we examined if several PARK2 SNPs influ-
ence the susceptibility to DNS following CO poisoning.
In a previous study, we conducted pooling-based
genome-wide association study in two independent sam-
ples of CO poisoning patients with or without DNS using
the Infinium human 660 W-Quad array. Replicated asso-
ciations were identified, and selected findings were con-
firmed by individual genotyping [13]. PARK2 was one of
the promising genes (unpublished data). In the present
case–control study, we compared the variant frequencies
of two PARK2 gene polymorphisms, rs1784594 (C/T)
and rs1893895 (G/A), in 514 Chinese-Han individuals
from Northern Henan Province, to determine if these
particular PARK2 variants influence DNS susceptibility.
Methods
Subjects
A total of 514 patients with acute CO poisoning were
recruited from three affiliated hospitals of Xinxiang MedicalTable 1 Demographic variables of DNS (case) and control pat
polymorphism
Characteristic rs1784594
Cases(n = 180) Controls
Age 60.05 ± 9.83 56.24
Sex (%)




Primary school 68(37.78) 99(3
Middle school 60(33.33) 75(2
Hypertension history (%) 67 (37.22) 119 (
Data presented as total number of instances (%) unless otherwise indicated.University, Xinxiang 1st People’s Hospital and Xinxiang
2nd People’s Hospital, respectively, from October 2006
to October 2010. Demographic variables were shown
in Table 1. Clinical diagnosis was made by specialty-
trained neurologists. The DNS patients were diagnosed
according to the following criteria [14,15]: (1) acute CO
poisoning leading to coma in the previous 1 to 2 months,
(2) an intervening “lucid interval” prior to the appearance
of delayed symptoms, (3) delayed acute dementia indicat-
ing widespread cortical dysfunction as the main clinical
manifestation, (4) EEG, CT, and/or MRI abnormalities,
(5) the exclusion of other causes of dementia, and (6)
older than 40 years. The acute CO poisoning patients
(controls) were chosen by the following criteria: (1) a his-
tory of acute CO poisoning as evidenced by coma and
elevated carboxyhemoglobin in blood at the time of pres-
entation, (2) no signs of DNS 90 days or more following
acute CO exposure, (3) exclusion of other etiologies, and
(4) older than 40 years. This study was approved by our
institutional Clinical Research Ethics Board and written
informed consent was obtained from each patient in-
volved in the study.
Genotyping
Genomic DNA was extracted from Peripheral blood
samples from each subject using the RelaxGene Blood
DNA System (Tiangen Biotech, Beijing, China). Five
SNPs met association signal in pooling-based genome-
wide association study (unpublished data, Additional file
1: Table S1). The biological functions and risks associ-
ated with individual SNP sites were evaluated using
FASTSNP online service [16], and the GeneCards data
base (http://www.genecards.org/). The SNPs ranked “high
risk” and with minor allele frequency (MAF) ≥ 0.05 in the
Chinese Beijing population in the HapMap database
were chosen. Finally, the PARK2 gene polymorphisms
rs1784594 and rs1893895 were chosen. The DNAients genotyped for the rs1784594 and rs1893895
rs1893895
(n = 262) Cases (n = 217) Controls (n = 226)
± 7.10 62.35 ± 8.31 58.05 ± 9.71





45.42) 162 (74.65) 154 (68.14)
Table 2 Allele and genotype frequencies of the rs1784594 and rs1893895 polymorphisms in DNS cases and controls
SNP Genotype (%) HWE
(P)
χ2 P value
Genotype Allele Genotype Allele
rs1784594 CC CT TT
Cases (n = 180) 31 (17.2) 93 (51.7) 56 (31.1) 0.472
7.01 6.56 0.030 0.010
Controls (n = 262) 32 (12.2) 117 (44.7) 113 (43.1) 0.840
rs1893895 GG GA AA
Cases (n = 217) 74 (34.1) 93 (42.9) 50 (23.0) 0.051
0.36 0.36 0.836 0.550
Controls (n = 226) 81 (35.8) 98 (43.4) 47 (20.8) 0.090
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reaction mixture con-taining Golden DNA poly-
merase (Gloden Fast PCR Kit, TIANGEN, Beijing,
China) with primers 5′-GTTCACACCTTCTGCCTT
GCTT-3′ and 5′- TCACAACACTGAGAGGCACT
GG-3′ for rs1784594; 5′-GTGACAGGACCCAGCTG
AAGAG-3′ and 5′-TGCAATGTCACAATCTTGGC
TC-3′ for rs1893895. The conditions used for PCR
amplification included an initial denaturation phase
at 94°C for 2 min, followed by 35 cycles of 94°C for
15 s, 59°C for 5 s, and 72°C for 15 s, and a final ex-
tension phase of 72°C for 2 min. As a quality con-
trol, 100 randomly selected samples were genotyped
by DNA sequencing.
PCR products were completely digested with the re-
striction enzyme (5U Bsh1236I for rs1784594, 5U NlaIII
for rs1893895). The fragments were separated on 2%
agarose gels and visualized under ultraviolet light after
staining with ethidium bromide using the 100 bp DNA
Ladder as a standard marker. The three genotypes
resulting from digestion with Bsh1236I were AA (82 bp,
99 bp), AG (32 bp, 82 bp, 99 bp, 150 bp) and GG (99 bp,
150 bp) for rs1784594. Similarly, the three genotypes
yielded by digestion with NlaIII were GG (122 bp,
223 bp), AG (122 bp, 223 bp, 345 bp) and AA (345 bp).Table 3 Rs1784594 association with response Group (adjuste
Model Genotype Controls
Codominant TT 113 (43.1%)
CT 117 (44.7%)
CC 32 (12.2%)
Dominant TT 113 (43.1%)
CT-CC 149 (56.9%)
Recessive TT-TC 230 (87.8%)
CC 32 (12.2%)
Overdominant TT-CC 145 (55.3%)
CT 117 (44.7%)
Log-additive — —Statistical analyses
All genetic analysis was performed using the SNPStats, a
web tool [17]. Genotype and allele frequency were com-
pared between two groups using the Pearson chi-square
test with co-dominant model. Hardy–Weinberg equilib-
rium (HWE) was assessed using the chi-square test with
one degree of freedom. Odds ratios (ORs) and 95% con-
fidence intervals (95% CI) were calculated to evaluate
the effects of alleles and genotypes. To evaluate interac-
tions between SNP and sex, a global test for interaction
was performed in the co-dominant model, in addition to
a test for the interaction in the linear trend of the nested
variable. Take into account a possible effect of age adjust
their models by age. A two-tailed P-value ≤ 0.05 was
considered significant.
Results
We compared variants of the PARK2 gene SNPs
rs1784594 (C/T) and rs1893895 (G/A) between CO poi-
soning patients presenting with delayed neurological se-
quelae (DNS, n = 231) and CO poisoning patients with
no lasting neurological deficits (controls, n = 283). Of
the total cases (514), 442 cases were genotyped for the
rs1784594 SNP and 443 for the rs1893895, while a sub-
set from each group (371) were genotyped for both.d by age)
Cases OR (95% CI) P value
56 (31.1%) 1.00 0.03
93 (51.7%) 1.62 (1.06-2.47)
31 (17.2%) 1.93 (1.07-3.47)
56 (31.1%) 1.00 0.0097
124 (68.9%) 1.69 (1.13-2.52)
149 (82.8%) 1.00 0.16
31 (17.2%) 1.47 (0.86-2.51)
87 (48.3%) 1.00 0.13
93 (51.7%) 1.34 (0.92-1.97)
— 1.44 (1.09-1.90) 0.011
Table 4 Genotype and allele frequencies of rs1784594 in female and male samples
Sex Genotype (%) χ2 P value
CC CT TT Genotype Allele Genotype Allele
Male Cases (n = 94) 16 (17.0) 48 (51.1) 30 (31.9)
3.101 2.622 0.212 0.105
Controls (n = 119) 16 (13.4) 51 (42.9) 52 (43.7)
Female Cases (n = 86) 15 (17.4) 45 (52.3) 26 (30.2)
4.155 3.98 0.125 0.045
Controls (n = 143) 16 (11.2) 66 (46.2) 61 (42.6)
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were not significantly different between cases and con-
trols genotyped for rs1784594 or rs1893895 (Age: P =
0.072 and P = 0.190; Sex Ratio: P = 0.053 and P = 0.114;
Hypertensive status: P = 0.086 and P = 0.096) (Table 1),
indicating well-matched groups. The SNPs were in
Hardy-Weinberg equilibrium in both the case and con-
trol group (Table 2).
The genotype and allele frequencies of both polymor-
phisms are presented in Table 2. There was a significant
difference in rs1784594 allele frequencies between DNS
cases and controls (OR = 1.42; 95%CI: 1.08-1.87; P <
0.05). Furthermore, the 1784594 TT genotype frequency
was significantly lower versus CC (OR = 1.95; 95%CI:
1.15-3.23; P < 0.05) and CT + CC (OR = 1.68; 95%CI:
1.11-2.54; P < 0.05) in DNS patients. When the model
was adjusted by age, the significant remained (Table 3).
In contrast, there were no significant associations be-
tween the rs1893895 G/A allelic variants and clinical
outcome.
To further examine the impact of rs1784594 on DNS
risk, cases and controls were divided by gender. The fe-
male DNS cases exhibited a significant difference in al-
lele frequencies (OR = 1.48; 95% CI: 1.01–2.17; P < 0.05)
compared to female controls (Table 4). But there is no
significant interaction between SNP and sex (Table 5).
Discussion
Mutations, deletions, and polymorphisms of the PARK2
gene have been associated with PD, cancer, susceptibility
to bacterial infections, and other diseases [9,18-20]. Re-
cently, a number of SNPs within PARK2 have been iden-
tified that are possible risk factors for PD [21-23].
Furthermore, early-onset PD, autism spectrum disorder,
and progressive supranuclear palsy have also been asso-
ciated with PARK2 mutations [24-26], suggesting that
these PARK2 mutations disrupt neural development orTable 5 Rs1784594 and sex cross-classification interaction tab
Genotype Female Mal
Controls Cases OR (95% CI) Controls Cases
TT 61 26 1.00 52 30
CT 66 45 1.60 (0.88-2.90) 51 48
CC 16 15 2.20 (0.95-5.10) 16 16decrease resistance to insult, leading to developmental
deficits or increasing susceptibility to diseases such as
DNS following CO poisoning.
In contrast to neurodegenerative diseases, most studies
on DNS following CO poisoning have focused on clin-
ical characteristics, and few studies have attempted to
link the propensity for DNS with specific genotypes
[7,27-29]. Our case–control study suggests that an allelic
variant of PARK2, the rs1784594 polymorphism, might
influence DNS risk in a Han population from Northern
Henan, China.
We measured the genotype frequencies of two PARK2
polymorphisms, rs1784594 and rs1893895, and found
that the C variant of rs1784594 may be a risk factor for
DNS. The allele frequencies indicated that the TT geno-
type might lower the risk for DNS after CO poisoning
by 1.7-fold compared to CC + CT. This suggested that
the T allele of rs1784594 may confer resistance against
DNS through some as yet unknown neuroprotective
mechanism. There was also a significant association be-
tween C/T allele distribution and clinical outcome in fe-
males, but not with any specific genotype. No significant
association was found between hypertension status and
DNS risk. Even after controlling for hypertension,
rs1893895 variant, and sex, the rs1784594 remained a
significant risk factor for DNS following CO poisoning.
To determine the gender effect, genotype and allele
frequency in both sexes were assessed. The female DNS
cases exhibited a significant difference in allele frequen-
cies of rs1784594 compared to female controls. But
there is no significant interaction between SNP and sex.
DNS was a disease resulting from interactions between
environmental factors (CO) and an individual’s biological
background. The aim of this study was to explore gen-
etic susceptibility about the normal human’s different
consequences after poisoning. The different caused by
gender effect is hard to ignore, especially in endocrine,le (n = 442, crude analysis)
e P value
OR (95% CI) Global test Sex within SNP SNP within sex
1.35 (0.71-2.57)
0.90 0.75 0.902.21 (1.21-4.04)
2.35 (1.02-5.39)
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specific association was often reported in other psych-
osis. The female-specific association may be attributed
to the interaction between estrogen and genes related to
brain development.
Conclusions
In conclusion, we demonstrated a significant association
between the PARK2 rs1784594 polymorphism and de-
layed neuropsychological sequelae following CO poison-
ing among the Han population from Northern Henan
Province. Thus, allelic variants of the PARK2 gene may
influence the susceptibility to DNS. It is unclear whether
other SNPs within PARK2 also influence the susceptibil-
ity to DNS. Such studies may help reveal the functional
mechanisms for DNS following CO poisoning and the
role of PARK2 mutations in neurodegeneration.
Additional file
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pooling-based genome-wide association study.
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